Investing
1088 Articles
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Friday.…
Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) is back in the rumor mill as far as a buyout, but this time the…
The 10-year Treasury hit yet another record low under 1.6% today and stocks are in the tank again due to…
A stock market that sells off eight of nine days is not a good market. Even the Facebook IPO is…
Blame whatever you want. A weaker U.S. economy, a weakening and flailing Europe, a move to socialism in France and…
Markets opened higher this morning following a lower-than-expected GDP growth estimate of 2.2%. That was weaker, but not awful (our…
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company. It is one of the…
How many DJIA components can raise their dividend in one week? Johnson & Johnson (NYSE: JNJ) answered that question as…
Ardea Biosciences, Inc. (NASDAQ: RDEA) is soaring today on news that AstraZeneca PLC (NYSE: AZN) is paying about $1.26 billion to…
Diabetes drug maker Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has hired bankers and lawyers to help the company find a buyer.…
Concerns about Spain and Italy renew capital markets’ rejection of area debt. (Reuters) Best Buy (NYSE: BBY) will have to…
Canadian-based drug company Cardiome Pharma Corp. (NASDAQ: CRME) announced this morning that Merck & Co. Inc. (NYSE: MRK) has cancelled…
Drug maker Merck & Co. Inc. (NYSE: MRK) this morning lowered its first quarter non-GAAP EPS estimate to $0.95-$0.98, well…
Drug maker Merck & Co. Inc. (NYSE: MRK) has released results of a phase III study of its investigational allergy…
The FDA announced today that the use of statins, common among people with high cholesterol, pose problems which were not…
Our top personal finance-related articles today. Your wallet will thank you later.